Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones, or bath salts. The vaccine blunts the illegal stimulant's effects on the brain, which could help recovering drug users who experience a relapse.
A treatment gap remains for many conditions involving damage to the liver, the body's main organ for removing toxins, among other functions. The Experimental Biology 2018 meeting (EB 2018) will feature important research announcements related to the causes of liver degradation and possible treatments.
Fear of dismissal or of losing their authorization keeps medical doctors trapped in their substance-use disorders, and instead of seeking help they attempt self-treatment. This is shown by a new study from Aarhus University.
Activity in decision-making brain regions of people who use recreational stimulants predicts who will discontinue use and who will develop a drug use disorder, according to a new study led by Martin Paulus, Ph.D., of Laureate Institute of Brain Research, Tulsa, Okla.
In a first-of-a-kind study, Washington State University scientists examined how peoples' self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home.
New research shows that online ads encouraging pregnant women to take up stop smoking support could be more effective than advice delivered in a clinical setting. The new study shows that commercial online advertising about cessation support could engage large numbers of women earlier in their pregnancies, and at a lower cost.
Scientists have for the first time found direct causal links between the neurotransmitter dopamine and avoidance -- behavior related to pain and fear. Researchers have long known that dopamine plays a key role in driving behavior related to pleasurable goals, such as food, sex and social interaction. In general, increasing dopamine boosts the drive toward these stimuli. But dopamine's role in allowing organisms to avoid negative events has remained mysterious.
A new study in The Lancet Public Health shows the rapid expansion of British Columbia's Take Home Naloxone program significantly reduced the number of fentanyl-related overdose deaths in 2016.
People released from prison who have both mental illness and substance use problems are at 12 times the risk of suffering injury compared to the general community, world-first research from the University of Melbourne has found. Risky drug use was a health concern for many people, but injury from causes other than drugs accounted for nine out of 10 injury events.
Frequent cannabis use by adolescents and young adults was associated with small reductions in cognitive function that appeared to diminish with abstinence over time.